Publications.
Estimating Quality of Life Decrements in Oncology Using Time to Death
Correcting for discounting and loss aversion in composite time trade-off
Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020
The Net Benefit of Personalized Medicine: a Systematic Literature Review and Regression Analysis
Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis
Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study
The potential impact of digial biomarkers in multiple slerosis in the Netherlands: an early HTA technology assessment of MS Sherpa
105P prognostic value of the NTRK fusion biomarker in the Netherlands
Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis
Distributional consequences of including survivor costs in economic evaluations distributional consequences of survivor costs in economic evaluations
Quality of life among people living with HIV in England and the Netherlands: a population-based study
The Mental Health Quality of Life Questionnaire (MHQoL): development and first psychometric evaluation of a new measure to assess quality of life in people with mental health problems
Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
Burden of providing informal care for patients with atrial fibrillation
A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure
Ravulizumab for paroxysmal nocturnal haemoglobinuria: a Single Technology Assessment
Pharmaceutical pricing: what is reasonable?
